Navigating An Evolving Global Regulatory Landscape

By Anusha Foy, Global Head of Regulatory Affairs, Clinical Solutions, IQVIA Biotech

The normal conduct of clinical trials has been significantly impacted across the globe by COVID-19, and every healthcare institution and pharmaceutical company has had to rapidly adapt. The global economy is struggling and industries in every sector have responded with amazing courage and tenacity in the face of an unparalleled threat. Our regulatory experts are closely following the evolution of regulatory guidance on COVID-19 and the approach taken by global regulatory agencies.